ログイン

HISTOPATHOLOGY & MT LAWS PROGRESS EXAM

HISTOPATHOLOGY & MT LAWS PROGRESS EXAM
100問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    First clinical laboratory in the Philippines: * 1/1 San Lazaro Hospital Research Institute for Tropical Medicine Manila Public Health Laboratory National Reference Laboratory

    Manila Public Health Laboratory

  • 2

    Introduced medical technology practice in the Philippines after World War II: * 0/1 Dr. Pio de Roda Dr. Prudencia Sta. Ana Dr. Mariano Icasiano 26th Medical Laboratory of the 6th US Army

    26th Medical Laboratory of the 6th US Army

  • 3

    RA 5527 consists of: * 1/1 30 sections 32 sections 50 sections 52 sections

    32 sections

  • 4

    Which of the following amends RA 5527 on June 11, 1978? * 0/1 RA 6138 PD 498 PD 1534

    PD 1534

  • 5

    All are sections of RA 5527 amended by PD 1534, except: * 0/1 Section 3 Section 8 Section 13 Section 18

    Section 18

  • 6

    All are qualifications of the Board of Medical Technology, except: * 1/1 Filipino citizen Good moral character Qualified Pathologist, or a duly registered MT In practice of laboratory medicine or MT for at least 5 years prior to his appointment Not a member of the faculty of any MT school for at least 2 years prior to appointment

    In practice of laboratory medicine or MT for at least 5 years prior to his appointment

  • 7

    Board of Medical Technology term of office: * 0/1 Hold office for ONE (1) YEAR after appointments or until their successors shall have been appointed and duly qualified Hold office for THREE (3) YEARS after appointments or until their successors shall have been appointed and duly qualified Hold office for FIVE (5) YEARS after appointments or until their successors shall have been appointed and duly qualified Hold office for SEVEN (7) YEARS after appointments or until their successors shall have been appointed and duly qualified

    Hold office for THREE (3) YEARS after appointments or until their successors shall have been appointed and duly qualified

  • 8

    Minor subject (10%) in the MT Board Exam: * 1/1 Clinical Chemistry Hematology Immunology, Serology & Blood Banking Clinical Microscopy

    Clinical Microscopy

  • 9

    In order to pass the MT examination, a candidate must obtain a general average of at least ___ in the written test. * 1/1 General average of at least 50% General average of at least 65% General average of at least 70% General average of at least 75%

    General average of at least 75%

  • 10

    Refresher course for applicants who have failed the Board Examination for the ___ time. * 1/1 First time Second time Third time Fourth time

    Third time

  • 11

    Certificate of Registration as Medical Technologist is issued to any successful applicant who has attained the age of: * 1/1 18 19 20 21

    21

  • 12

    Revocation: * 1/1 Unanimous vote (3/3) Majority vote (2/3)

    Unanimous vote (3/3)

  • 13

    Suspension: * 1/1 Unanimous vote (3/3) Majority vote (2/3)

    Majority vote (2/3)

  • 14

    Which of the following can only be done in a tertiary category laboratory? * 0/1 Crossmatching Routine chemistry Routine hematology Special hematology

    Special hematology

  • 15

    Start of renewal of Clinical Laboratory License: * 1/1 October 1 November 1 December 1 January 1

    October 1

  • 16

    The LICENSE TO OPERATE (LTO) issued to the CLINICAL LABORATORY is valid for: * 0/1 One year Two years Three years Five years

    One year

  • 17

    Acceptable patient identifiers include: * 0/1 Patient's name, gender, medical record number Patient's name, gender, date of birth Patient's name, requesting physician, medical record number Patient's name, date of birth, medical record number

    Patient's name, date of birth, medical record number

  • 18

    LICENSE TO OPERATE (LTO) Blood Service Facilities is valid for a period of ____ years. * 1/1 1 year 2 years 3 years 5 years

    3 years

  • 19

    According to DOH A.O. 2020-0031, certificate of accreditation of laboratories for DRINKING WATER ANALYSIS is valid for __ year(s) and expires on the last day of December. TAKE NOTE OF YEAR 2020 DOH REVISION. * 0/1 One year Two years Three years Five years

    Three years

  • 20

    Part of drinking water analysis, except: * 1/1 Calcium Fecal coliform test Sodium Potassium

    Potassium

  • 21

    License and accredit drug testing centers in each province and city: * 0/1 DOH PDEA PNP PRC

    DOH

  • 22

    Methylenedioxymethamphetamine (MDMA): * 1/1 Shabu Meth Ice Ecstasy

    Ecstasy

  • 23

    Random drug test: * 1/1 Applicants for firearm’s license Officers and members of the military, police and other law enforcers Students of secondary and tertiary schools Candidates for public office whether appointed or elected both in the national or local government

    Students of secondary and tertiary schools

  • 24

    A drug test is valid for: * 1/1 Six weeks Six months One year Two years

    One year

  • 25

    All results of HIV/AIDS testing shall be confidential and shall be released only to the following persons, except: * 1/1 Person who submitted himself/herself to such test Boyfriend of the patient Either parent of a minor child who has been tested Legal guardian in the case of insane persons or orphans Person authorized to receive such results in conjunction with the AIDSWATCH program

    Boyfriend of the patient

  • 26

    The Professional Regulation Commission, otherwise known as the PRC, is a ____-man commission attached to office of the President for general direction and coordination. [Currently, to DOLE] * 1/1 Two-man Three-man Four-man Five-man

    Three-man

  • 27

    The current (September 2022) PRC CHAIRPERSON is: * 1/1 Marilyn Barza Teofilo Pilando Charito Zamora Jose Cueto

    Charito Zamora

  • 28

    If a medical technologist was not able to complete the number of CPD units upon renewal of PRC license, he may sign a/an: [ONLY UP TO DECEMBER 2023] * 1/1 Affidavit of undertaking Certificate of exemption Certificate of registration Suspension order

    Affidavit of undertaking

  • 29

    An act done to avoid harming the patients: * 1/1 Beneficence Non-maleficence Autonomy Justice

    Non-maleficence

  • 30

    Obligation of MT to the patient: * 1/1 Compliance to PRC Compliance to the department of health Comprehensive health education Strive for excellence in professional practice

    Strive for excellence in professional practice

  • 31

    All traits are mentioned in the MT CODE OF ETHICS, except: * 0/1 Honesty Humility Integrity Reliability

    Humility

  • 32

    Fill in the blank (Code of Ethics): Be dedicated to ____. * 0/1 Fairness to all and in a spirit of brotherhood toward other members of the profession Law and shall not participate in illegal work Responsibilities inherent to being a professional Use of clinical laboratory science to promote life and benefit mankind

    Use of clinical laboratory science to promote life and benefit mankind

  • 33

    Continuing Professional Development Act of 2016: * 1/1 RA 7719 RA 9288 RA 10912 RA 7170

    RA 10912

  • 34

    Published standards for GOOD LABORATORY PRACTICE: * 1/1 CDC DOH PRC WHO

    WHO

  • 35

    Components of quality assurance: * 1/1 Pre-analytical variables Analytical variables Post-analytical variables All of these

    All of these

  • 36

    An example of cellular adaptation is: * 0/1 Edema Inflammation Neoplasia Dysplasia

    Dysplasia

  • 37

    Low temperature: * 1/1 Enhance fixation Retard fixation Variable No effect

    Retard fixation

  • 38

    Stopping all cellular activities so that the cells can be viewed under the microscope as if they are still in their original living state: * 0/1 Decalcification Embedding Fixation Staining

    Fixation

  • 39

    Fixative for electron microscopy: * 1/1 Carnoy's Formalin Glutaraldehyde Zenker

    Glutaraldehyde

  • 40

    Most common and fastest decalcifying agent used: * 1/1 Formic acid Hydrochloric acid Nitric acid Sulfurous acid

    Nitric acid

  • 41

    For most instances, dehydration starts by placing the fixed specimen in: * 1/1 70% ethyl alcohol 95% ethyl alcohol Absolute alcohol Xylene

    70% ethyl alcohol

  • 42

    Transition step between dehydration and infiltration with the embedding medium: * 1/1 Fixation Clearing Infiltration Mounting

    Clearing

  • 43

    Enclosed tissue processor: * 0/1 Mechanical transfer Dip and dunk Fluid transfer Tissue transfer

    Fluid transfer

  • 44

    What are the processes (IN ORDER) done by the automatic tissue processor: * 1/1 Fixation, clearing, dehydration and infiltration Fixation, infiltration, dehydration and clearing Fixation, dehydration, clearing and infiltration Fixation, dehydration, infiltration and clearing

    Fixation, dehydration, clearing and infiltration

  • 45

    These knives are used to cut block for ELECTRON MICROSCOPY (EM): * 1/1 Disposal blades Steel knives Diamond or glass knives Magnetic blades

    Diamond or glass knives

  • 46

    Sections fail to form ribbons: * 0/1 Hard spot in tissue due to calcium Sections are too thick Paraffin is impure Knife edge is dirty

    Sections are too thick

  • 47

    Effect of basic pH to ripening process: * 0/1 Slower oxidizing process More rapid oxidizing process Variable No effect

    More rapid oxidizing process

  • 48

    RETICULIN FIBERS IN GOMORI’S silver impregnation stain: * 0/1 Black Blue Red Green

    Black

  • 49

    A stain containing silver nitrate for demonstration of spirochetes: * 1/1 Fite-Faraco Warthin-Starry Masson-Fontana Mallory's PTAH

    Warthin-Starry

  • 50

    Frozen sections are stained by hand because: * 1/1 Staining is more accurate Prevent overstaining Faster for one or a few individual sections Predictable colors

    Faster for one or a few individual sections

  • 51

    _______ are raised against specific cellular _____ and then conjugated with a _______. * 0/1 Antigen, antibody, visual marker Visual marker, antigen, antibody Antibody, antigen, visual marker Visual marker, antibody, antigen

    Antibody, antigen, visual marker

  • 52

    Gastrointestinal specimens, except: * 0/1 Gastric lavage Gastric brush Fine needle aspirate (submucosal lesions) Induced vomiting

    Induced vomiting

  • 53

    Liquid-based cytology samples: * 1/1 Body fluids Touch imprint Brush sampling Skin scrape

    Body fluids

  • 54

    It is considered to be a most sensitive and specific reagent for lipid staining: * 1/1 Sudan III Sudan IV Sudan Black Oil Red O

    Sudan Black

  • 55

    One measure of the efficiency of a surgical pathology service: * 1/1 Rapidity of accurate reporting the diagnosis to clinicians Rapidity of tissue processing Sufficiency of tissue preservation Sufficiency of reagents and standards

    Rapidity of accurate reporting the diagnosis to clinicians

  • 56

    Objective of a quality assurance program in histopathology: * 1/1 Ensure to process the tissues Ensure acceptable service Ensure to follow standards Ensure the completeness, accuracy and timeliness of a histopathology report

    Ensure the completeness, accuracy and timeliness of a histopathology report

  • 57

    Primary objective in quality and safety control programs in histopathology laboratories: * 0/1 Correctness of interpretation of reports Ensure correct sampling Ensure accurate treatment to patient Promotion of health and safety of patient, laboratory personnel and environment

    Promotion of health and safety of patient, laboratory personnel and environment

  • 58

    Which of the following fixatives contains picric acid, formalin, and acetic acid? * 0/1 Zenker Helly Bouin Zamboni

    Bouin

  • 59

    The volume of fixative should exceed the volume of the tissue by: * 1/1 1 to 2 times 5 to 10 times 10 to 20 times 25 to 50 times

    10 to 20 times

  • 60

    Which of the following fixatives contains formalin, potassium dichromate, and mercuric chloride? * 0/1 Zenker Helly Carnoy Orth

    Helly

  • 61

    Precipitate left in tissues that have been fixed in solutions containing mercuric chloride may be removed by immersion in: * 0/1 Running water Sodium thiosulfate Weak ammonia water Iodine

    Iodine

  • 62

    Commercial stock formaldehyde solutions contain: * 1/1 4% formaldehyde 10% formaldehyde 37 to 40% formaldehyde 98 to 100% formaldehyde

    37 to 40% formaldehyde

  • 63

    Formalin pigment may be removed from tissue by: * 1/1 Running water Alcoholic iodine Alcoholic picric acid Potassium permanganate

    Alcoholic picric acid

  • 64

    To prepare a 10% solution of formalin, which of the following amounts of water should be added to 100 mL of stock formaldehyde: * 1/1 1,000 mL 900 mL 450 mL 10 mL

    900 mL

  • 65

    Carnoy fluid is prepared with acetic acid, alcohol, and: * 0/1 Chloroform Formalin Acetone Osmium tetroxide

    Chloroform

  • 66

    The first and most important procedure in the preparation of a tissue for microscopic examination is the choice of: * 1/1 Fixative Dehydrating agent Clearing agent Staining technique

    Fixative

  • 67

    Generally, an increase in the temperature of the fixative solution: * 0/1 Decreases the tissue autolysis Decreases the fixative penetration Increases the speed of fixation Increases the volume of fixative needed

    Increases the speed of fixation

  • 68

    Which of the following may cause tissue to become overhardened? * 1/1 Prolonged fixation Abbreviated fixation Inadequate dehydration Incomplete clearing

    Prolonged fixation

  • 69

    To prevent polymerization of formaldehyde, which of the following is added to the commercial stock solutions? * 0/1 Methyl alcohol Formic acid Paraformaldehyde Sodium phosphate

    Methyl alcohol

  • 70

    Which of the following is a dehydrating agent? * 1/1 Formalin Xylene Benzene Alcohol

    Alcohol

  • 71

    A clearing agent for use in processing tissues for paraffin embedding must be miscible with the: * 0/1 Fixative and paraffin Dehydrant and paraffin Fixative and dehydrant Paraffin and water

    Dehydrant and paraffin

  • 72

    Dioxane is a reagent that can be used: * 1/1 For both fixing and dehydrating tissues For both dehydrating and clearing tissues In very small volume ratios For long periods without changing

    For both dehydrating and clearing tissues

  • 73

    A reagent that CANNOT be used for dehydrating tissue is: * 1/1 Benzene Absolute alcohol Dioxane Acetone

    Benzene

  • 74

    Which of the following chemicals is NOT a clearing agent? * 1/1 Chloroform Dioxane Ethanol Xylene

    Ethanol

  • 75

    The process of removing water from tissue is called: * 1/1 Dehydration Reduction Oxidation Clearing

    Dehydration

  • 76

    The dehydration and clearing steps can be omitted when using: * 1/1 Celloidin Epoxy resin Glycol methacrylate Water-soluble wax

    Water-soluble wax

  • 77

    During microtomy, it is noted that most of the tissue is very hard and shrunken. One of the first things to check to prevent its happening in the future is the: * 1/1 Presence of water in the clearing agent pH of the fixative Temperature of the infiltrating paraffin Freshness of the reagents on the processor

    Temperature of the infiltrating paraffin

  • 78

    The temperature of the oven used to maintain a supply of melted paraffin for embedding tissue should be about: * 1/1 43C 43F 60C 60F

    60C

  • 79

    When using a microscope with a x10 ocular and a x40 objective, the total magnification is approximately: * 1/1 100 400 1,000 4,000

    400

  • 80

    The microwave oven creates heat in staining solutions by: * 1/1 Convection Conduction Nonionizing radiation Electrolytic action

    Nonionizing radiation

  • 81

    Harris hematoxylin is used on tissue sections to stain: * 1/1 Fat Glycogen Nuclei Cytoplasm

    Nuclei

  • 82

    Ripening of hematoxylin is a process of: * 1/1 Hydrolysis Oxidation Mordanting Reduction

    Oxidation

  • 83

    The active staining ingredient in ripened hematoxylin solutions is: * 0/1 Hematin Hematein Hematoxylin Hemosiderin

    Hematein

  • 84

    Hematein The most important step in regressive hematoxylin staining is: * 1/1 Postmordanting in picric acid Use of hematoxylin containing acetic acid Differentiation in acid-alcohol Washing in water after the hematoxylin

    Differentiation in acid-alcohol

  • 85

    Mordants are used to: * 0/1 Change the refractive index of the tissue Help differentiate stains Link tissue constituents more closely to the dye Oxidize staining solutions

    Link tissue constituents more closely to the dye

  • 86

    The combination of a dye and a mordant is called a/an: * 0/1 Base Accelerator Lake Buffer

    Lake

  • 87

    Mercuric oxide (or sodium iodate) is used in Harris hematoxylin to: * 0/1 Form hematein Prevent oxidation Serve as the mordant Stabilize the solution

    Form hematein

  • 88

    DNA can be demonstrated with: * 1/1 Eosin Pyronin Feulgen reaction Fast green

    Feulgen reaction

  • 89

    The mordant in Weigert hematoxylin is: * 0/1 Iron Aluminum Mercury Tungsten

    Iron

  • 90

    Acetic acid is added to Harris hematoxylin to: * 0/1 Keep heterochromatin from staining Make nuclear staining more specific Ripen the hematoxylin Form a dye lake

    Make nuclear staining more specific

  • 91

    Which of the following is stained rose by the methyl green-pyronin (MGP) technique? * 0/1 Heterochromatin DNA RNA Golgi apparatus

    RNA

  • 92

    Differentiating in the H&E stain is an example of using: * 0/1 Excess mordant Weak acid Oxidizers Buffers

    Weak acid

  • 93

    The Feulgen reaction demonstrates: * 0/1 DNA only RNA only Both DNA and RNA Phosphoric acid groups

    DNA only

  • 94

    Sections for special stains have been accidentally stained with hematoxylin. To remove the hematoxylin, place the sections in: * 0/1 Acid alcohol Dilute ammonia Lithium carbonate Isopropyl alcohol

    Acid alcohol

  • 95

    Glycogen is best demonstrated by the use of: * 1/1 Crystal violet Mayer mucicarmine PAS with and without diastase Alcian blue with and without hyaluronidase

    PAS with and without diastase

  • 96

    Amyloid can be demonstrated with: * 1/1 Congo red Mayer mucicarmine Cresyl echt violet Alcian blue

    Congo red

  • 97

    Which of the following methods best demonstrates elastic tissue? * 0/1 Verhoeff Silver impreganation Gomori trichrome PAS

    Verhoeff

  • 98

    The oil red O stain requires which of the following sections? * 0/1 Paraffin Celloidin Frozen Plastic

    Frozen

  • 99

    The oil red O stain might be used to demonstrate: * 1/1 Rhabdomyosarcomas Leiomyosarcomas Liposarcomas Adenocarcinomas

    Liposarcomas

  • 100

    The best stain for the demonstration of Mycobacterium leprae is the: * 1/1 Fite PAS Kinyoun Gram

    Fite

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    First clinical laboratory in the Philippines: * 1/1 San Lazaro Hospital Research Institute for Tropical Medicine Manila Public Health Laboratory National Reference Laboratory

    Manila Public Health Laboratory

  • 2

    Introduced medical technology practice in the Philippines after World War II: * 0/1 Dr. Pio de Roda Dr. Prudencia Sta. Ana Dr. Mariano Icasiano 26th Medical Laboratory of the 6th US Army

    26th Medical Laboratory of the 6th US Army

  • 3

    RA 5527 consists of: * 1/1 30 sections 32 sections 50 sections 52 sections

    32 sections

  • 4

    Which of the following amends RA 5527 on June 11, 1978? * 0/1 RA 6138 PD 498 PD 1534

    PD 1534

  • 5

    All are sections of RA 5527 amended by PD 1534, except: * 0/1 Section 3 Section 8 Section 13 Section 18

    Section 18

  • 6

    All are qualifications of the Board of Medical Technology, except: * 1/1 Filipino citizen Good moral character Qualified Pathologist, or a duly registered MT In practice of laboratory medicine or MT for at least 5 years prior to his appointment Not a member of the faculty of any MT school for at least 2 years prior to appointment

    In practice of laboratory medicine or MT for at least 5 years prior to his appointment

  • 7

    Board of Medical Technology term of office: * 0/1 Hold office for ONE (1) YEAR after appointments or until their successors shall have been appointed and duly qualified Hold office for THREE (3) YEARS after appointments or until their successors shall have been appointed and duly qualified Hold office for FIVE (5) YEARS after appointments or until their successors shall have been appointed and duly qualified Hold office for SEVEN (7) YEARS after appointments or until their successors shall have been appointed and duly qualified

    Hold office for THREE (3) YEARS after appointments or until their successors shall have been appointed and duly qualified

  • 8

    Minor subject (10%) in the MT Board Exam: * 1/1 Clinical Chemistry Hematology Immunology, Serology & Blood Banking Clinical Microscopy

    Clinical Microscopy

  • 9

    In order to pass the MT examination, a candidate must obtain a general average of at least ___ in the written test. * 1/1 General average of at least 50% General average of at least 65% General average of at least 70% General average of at least 75%

    General average of at least 75%

  • 10

    Refresher course for applicants who have failed the Board Examination for the ___ time. * 1/1 First time Second time Third time Fourth time

    Third time

  • 11

    Certificate of Registration as Medical Technologist is issued to any successful applicant who has attained the age of: * 1/1 18 19 20 21

    21

  • 12

    Revocation: * 1/1 Unanimous vote (3/3) Majority vote (2/3)

    Unanimous vote (3/3)

  • 13

    Suspension: * 1/1 Unanimous vote (3/3) Majority vote (2/3)

    Majority vote (2/3)

  • 14

    Which of the following can only be done in a tertiary category laboratory? * 0/1 Crossmatching Routine chemistry Routine hematology Special hematology

    Special hematology

  • 15

    Start of renewal of Clinical Laboratory License: * 1/1 October 1 November 1 December 1 January 1

    October 1

  • 16

    The LICENSE TO OPERATE (LTO) issued to the CLINICAL LABORATORY is valid for: * 0/1 One year Two years Three years Five years

    One year

  • 17

    Acceptable patient identifiers include: * 0/1 Patient's name, gender, medical record number Patient's name, gender, date of birth Patient's name, requesting physician, medical record number Patient's name, date of birth, medical record number

    Patient's name, date of birth, medical record number

  • 18

    LICENSE TO OPERATE (LTO) Blood Service Facilities is valid for a period of ____ years. * 1/1 1 year 2 years 3 years 5 years

    3 years

  • 19

    According to DOH A.O. 2020-0031, certificate of accreditation of laboratories for DRINKING WATER ANALYSIS is valid for __ year(s) and expires on the last day of December. TAKE NOTE OF YEAR 2020 DOH REVISION. * 0/1 One year Two years Three years Five years

    Three years

  • 20

    Part of drinking water analysis, except: * 1/1 Calcium Fecal coliform test Sodium Potassium

    Potassium

  • 21

    License and accredit drug testing centers in each province and city: * 0/1 DOH PDEA PNP PRC

    DOH

  • 22

    Methylenedioxymethamphetamine (MDMA): * 1/1 Shabu Meth Ice Ecstasy

    Ecstasy

  • 23

    Random drug test: * 1/1 Applicants for firearm’s license Officers and members of the military, police and other law enforcers Students of secondary and tertiary schools Candidates for public office whether appointed or elected both in the national or local government

    Students of secondary and tertiary schools

  • 24

    A drug test is valid for: * 1/1 Six weeks Six months One year Two years

    One year

  • 25

    All results of HIV/AIDS testing shall be confidential and shall be released only to the following persons, except: * 1/1 Person who submitted himself/herself to such test Boyfriend of the patient Either parent of a minor child who has been tested Legal guardian in the case of insane persons or orphans Person authorized to receive such results in conjunction with the AIDSWATCH program

    Boyfriend of the patient

  • 26

    The Professional Regulation Commission, otherwise known as the PRC, is a ____-man commission attached to office of the President for general direction and coordination. [Currently, to DOLE] * 1/1 Two-man Three-man Four-man Five-man

    Three-man

  • 27

    The current (September 2022) PRC CHAIRPERSON is: * 1/1 Marilyn Barza Teofilo Pilando Charito Zamora Jose Cueto

    Charito Zamora

  • 28

    If a medical technologist was not able to complete the number of CPD units upon renewal of PRC license, he may sign a/an: [ONLY UP TO DECEMBER 2023] * 1/1 Affidavit of undertaking Certificate of exemption Certificate of registration Suspension order

    Affidavit of undertaking

  • 29

    An act done to avoid harming the patients: * 1/1 Beneficence Non-maleficence Autonomy Justice

    Non-maleficence

  • 30

    Obligation of MT to the patient: * 1/1 Compliance to PRC Compliance to the department of health Comprehensive health education Strive for excellence in professional practice

    Strive for excellence in professional practice

  • 31

    All traits are mentioned in the MT CODE OF ETHICS, except: * 0/1 Honesty Humility Integrity Reliability

    Humility

  • 32

    Fill in the blank (Code of Ethics): Be dedicated to ____. * 0/1 Fairness to all and in a spirit of brotherhood toward other members of the profession Law and shall not participate in illegal work Responsibilities inherent to being a professional Use of clinical laboratory science to promote life and benefit mankind

    Use of clinical laboratory science to promote life and benefit mankind

  • 33

    Continuing Professional Development Act of 2016: * 1/1 RA 7719 RA 9288 RA 10912 RA 7170

    RA 10912

  • 34

    Published standards for GOOD LABORATORY PRACTICE: * 1/1 CDC DOH PRC WHO

    WHO

  • 35

    Components of quality assurance: * 1/1 Pre-analytical variables Analytical variables Post-analytical variables All of these

    All of these

  • 36

    An example of cellular adaptation is: * 0/1 Edema Inflammation Neoplasia Dysplasia

    Dysplasia

  • 37

    Low temperature: * 1/1 Enhance fixation Retard fixation Variable No effect

    Retard fixation

  • 38

    Stopping all cellular activities so that the cells can be viewed under the microscope as if they are still in their original living state: * 0/1 Decalcification Embedding Fixation Staining

    Fixation

  • 39

    Fixative for electron microscopy: * 1/1 Carnoy's Formalin Glutaraldehyde Zenker

    Glutaraldehyde

  • 40

    Most common and fastest decalcifying agent used: * 1/1 Formic acid Hydrochloric acid Nitric acid Sulfurous acid

    Nitric acid

  • 41

    For most instances, dehydration starts by placing the fixed specimen in: * 1/1 70% ethyl alcohol 95% ethyl alcohol Absolute alcohol Xylene

    70% ethyl alcohol

  • 42

    Transition step between dehydration and infiltration with the embedding medium: * 1/1 Fixation Clearing Infiltration Mounting

    Clearing

  • 43

    Enclosed tissue processor: * 0/1 Mechanical transfer Dip and dunk Fluid transfer Tissue transfer

    Fluid transfer

  • 44

    What are the processes (IN ORDER) done by the automatic tissue processor: * 1/1 Fixation, clearing, dehydration and infiltration Fixation, infiltration, dehydration and clearing Fixation, dehydration, clearing and infiltration Fixation, dehydration, infiltration and clearing

    Fixation, dehydration, clearing and infiltration

  • 45

    These knives are used to cut block for ELECTRON MICROSCOPY (EM): * 1/1 Disposal blades Steel knives Diamond or glass knives Magnetic blades

    Diamond or glass knives

  • 46

    Sections fail to form ribbons: * 0/1 Hard spot in tissue due to calcium Sections are too thick Paraffin is impure Knife edge is dirty

    Sections are too thick

  • 47

    Effect of basic pH to ripening process: * 0/1 Slower oxidizing process More rapid oxidizing process Variable No effect

    More rapid oxidizing process

  • 48

    RETICULIN FIBERS IN GOMORI’S silver impregnation stain: * 0/1 Black Blue Red Green

    Black

  • 49

    A stain containing silver nitrate for demonstration of spirochetes: * 1/1 Fite-Faraco Warthin-Starry Masson-Fontana Mallory's PTAH

    Warthin-Starry

  • 50

    Frozen sections are stained by hand because: * 1/1 Staining is more accurate Prevent overstaining Faster for one or a few individual sections Predictable colors

    Faster for one or a few individual sections

  • 51

    _______ are raised against specific cellular _____ and then conjugated with a _______. * 0/1 Antigen, antibody, visual marker Visual marker, antigen, antibody Antibody, antigen, visual marker Visual marker, antibody, antigen

    Antibody, antigen, visual marker

  • 52

    Gastrointestinal specimens, except: * 0/1 Gastric lavage Gastric brush Fine needle aspirate (submucosal lesions) Induced vomiting

    Induced vomiting

  • 53

    Liquid-based cytology samples: * 1/1 Body fluids Touch imprint Brush sampling Skin scrape

    Body fluids

  • 54

    It is considered to be a most sensitive and specific reagent for lipid staining: * 1/1 Sudan III Sudan IV Sudan Black Oil Red O

    Sudan Black

  • 55

    One measure of the efficiency of a surgical pathology service: * 1/1 Rapidity of accurate reporting the diagnosis to clinicians Rapidity of tissue processing Sufficiency of tissue preservation Sufficiency of reagents and standards

    Rapidity of accurate reporting the diagnosis to clinicians

  • 56

    Objective of a quality assurance program in histopathology: * 1/1 Ensure to process the tissues Ensure acceptable service Ensure to follow standards Ensure the completeness, accuracy and timeliness of a histopathology report

    Ensure the completeness, accuracy and timeliness of a histopathology report

  • 57

    Primary objective in quality and safety control programs in histopathology laboratories: * 0/1 Correctness of interpretation of reports Ensure correct sampling Ensure accurate treatment to patient Promotion of health and safety of patient, laboratory personnel and environment

    Promotion of health and safety of patient, laboratory personnel and environment

  • 58

    Which of the following fixatives contains picric acid, formalin, and acetic acid? * 0/1 Zenker Helly Bouin Zamboni

    Bouin

  • 59

    The volume of fixative should exceed the volume of the tissue by: * 1/1 1 to 2 times 5 to 10 times 10 to 20 times 25 to 50 times

    10 to 20 times

  • 60

    Which of the following fixatives contains formalin, potassium dichromate, and mercuric chloride? * 0/1 Zenker Helly Carnoy Orth

    Helly

  • 61

    Precipitate left in tissues that have been fixed in solutions containing mercuric chloride may be removed by immersion in: * 0/1 Running water Sodium thiosulfate Weak ammonia water Iodine

    Iodine

  • 62

    Commercial stock formaldehyde solutions contain: * 1/1 4% formaldehyde 10% formaldehyde 37 to 40% formaldehyde 98 to 100% formaldehyde

    37 to 40% formaldehyde

  • 63

    Formalin pigment may be removed from tissue by: * 1/1 Running water Alcoholic iodine Alcoholic picric acid Potassium permanganate

    Alcoholic picric acid

  • 64

    To prepare a 10% solution of formalin, which of the following amounts of water should be added to 100 mL of stock formaldehyde: * 1/1 1,000 mL 900 mL 450 mL 10 mL

    900 mL

  • 65

    Carnoy fluid is prepared with acetic acid, alcohol, and: * 0/1 Chloroform Formalin Acetone Osmium tetroxide

    Chloroform

  • 66

    The first and most important procedure in the preparation of a tissue for microscopic examination is the choice of: * 1/1 Fixative Dehydrating agent Clearing agent Staining technique

    Fixative

  • 67

    Generally, an increase in the temperature of the fixative solution: * 0/1 Decreases the tissue autolysis Decreases the fixative penetration Increases the speed of fixation Increases the volume of fixative needed

    Increases the speed of fixation

  • 68

    Which of the following may cause tissue to become overhardened? * 1/1 Prolonged fixation Abbreviated fixation Inadequate dehydration Incomplete clearing

    Prolonged fixation

  • 69

    To prevent polymerization of formaldehyde, which of the following is added to the commercial stock solutions? * 0/1 Methyl alcohol Formic acid Paraformaldehyde Sodium phosphate

    Methyl alcohol

  • 70

    Which of the following is a dehydrating agent? * 1/1 Formalin Xylene Benzene Alcohol

    Alcohol

  • 71

    A clearing agent for use in processing tissues for paraffin embedding must be miscible with the: * 0/1 Fixative and paraffin Dehydrant and paraffin Fixative and dehydrant Paraffin and water

    Dehydrant and paraffin

  • 72

    Dioxane is a reagent that can be used: * 1/1 For both fixing and dehydrating tissues For both dehydrating and clearing tissues In very small volume ratios For long periods without changing

    For both dehydrating and clearing tissues

  • 73

    A reagent that CANNOT be used for dehydrating tissue is: * 1/1 Benzene Absolute alcohol Dioxane Acetone

    Benzene

  • 74

    Which of the following chemicals is NOT a clearing agent? * 1/1 Chloroform Dioxane Ethanol Xylene

    Ethanol

  • 75

    The process of removing water from tissue is called: * 1/1 Dehydration Reduction Oxidation Clearing

    Dehydration

  • 76

    The dehydration and clearing steps can be omitted when using: * 1/1 Celloidin Epoxy resin Glycol methacrylate Water-soluble wax

    Water-soluble wax

  • 77

    During microtomy, it is noted that most of the tissue is very hard and shrunken. One of the first things to check to prevent its happening in the future is the: * 1/1 Presence of water in the clearing agent pH of the fixative Temperature of the infiltrating paraffin Freshness of the reagents on the processor

    Temperature of the infiltrating paraffin

  • 78

    The temperature of the oven used to maintain a supply of melted paraffin for embedding tissue should be about: * 1/1 43C 43F 60C 60F

    60C

  • 79

    When using a microscope with a x10 ocular and a x40 objective, the total magnification is approximately: * 1/1 100 400 1,000 4,000

    400

  • 80

    The microwave oven creates heat in staining solutions by: * 1/1 Convection Conduction Nonionizing radiation Electrolytic action

    Nonionizing radiation

  • 81

    Harris hematoxylin is used on tissue sections to stain: * 1/1 Fat Glycogen Nuclei Cytoplasm

    Nuclei

  • 82

    Ripening of hematoxylin is a process of: * 1/1 Hydrolysis Oxidation Mordanting Reduction

    Oxidation

  • 83

    The active staining ingredient in ripened hematoxylin solutions is: * 0/1 Hematin Hematein Hematoxylin Hemosiderin

    Hematein

  • 84

    Hematein The most important step in regressive hematoxylin staining is: * 1/1 Postmordanting in picric acid Use of hematoxylin containing acetic acid Differentiation in acid-alcohol Washing in water after the hematoxylin

    Differentiation in acid-alcohol

  • 85

    Mordants are used to: * 0/1 Change the refractive index of the tissue Help differentiate stains Link tissue constituents more closely to the dye Oxidize staining solutions

    Link tissue constituents more closely to the dye

  • 86

    The combination of a dye and a mordant is called a/an: * 0/1 Base Accelerator Lake Buffer

    Lake

  • 87

    Mercuric oxide (or sodium iodate) is used in Harris hematoxylin to: * 0/1 Form hematein Prevent oxidation Serve as the mordant Stabilize the solution

    Form hematein

  • 88

    DNA can be demonstrated with: * 1/1 Eosin Pyronin Feulgen reaction Fast green

    Feulgen reaction

  • 89

    The mordant in Weigert hematoxylin is: * 0/1 Iron Aluminum Mercury Tungsten

    Iron

  • 90

    Acetic acid is added to Harris hematoxylin to: * 0/1 Keep heterochromatin from staining Make nuclear staining more specific Ripen the hematoxylin Form a dye lake

    Make nuclear staining more specific

  • 91

    Which of the following is stained rose by the methyl green-pyronin (MGP) technique? * 0/1 Heterochromatin DNA RNA Golgi apparatus

    RNA

  • 92

    Differentiating in the H&E stain is an example of using: * 0/1 Excess mordant Weak acid Oxidizers Buffers

    Weak acid

  • 93

    The Feulgen reaction demonstrates: * 0/1 DNA only RNA only Both DNA and RNA Phosphoric acid groups

    DNA only

  • 94

    Sections for special stains have been accidentally stained with hematoxylin. To remove the hematoxylin, place the sections in: * 0/1 Acid alcohol Dilute ammonia Lithium carbonate Isopropyl alcohol

    Acid alcohol

  • 95

    Glycogen is best demonstrated by the use of: * 1/1 Crystal violet Mayer mucicarmine PAS with and without diastase Alcian blue with and without hyaluronidase

    PAS with and without diastase

  • 96

    Amyloid can be demonstrated with: * 1/1 Congo red Mayer mucicarmine Cresyl echt violet Alcian blue

    Congo red

  • 97

    Which of the following methods best demonstrates elastic tissue? * 0/1 Verhoeff Silver impreganation Gomori trichrome PAS

    Verhoeff

  • 98

    The oil red O stain requires which of the following sections? * 0/1 Paraffin Celloidin Frozen Plastic

    Frozen

  • 99

    The oil red O stain might be used to demonstrate: * 1/1 Rhabdomyosarcomas Leiomyosarcomas Liposarcomas Adenocarcinomas

    Liposarcomas

  • 100

    The best stain for the demonstration of Mycobacterium leprae is the: * 1/1 Fite PAS Kinyoun Gram

    Fite